NHS National Generic Pharmaceuticals Wave 13

NHS National Generic Pharmaceuticals Wave 13

Invitation to offer for NHS National Generic Pharmaceuticals Wave 13. Documents attached.

NHS National Generic Pharmaceuticals Wave 13

Contract summary

 

Industry

  • Pharmaceutical products – 33600000

Location of contract

East Midlands, East of England, London, North East, North West, South East, South West, West Midlands, Yorkshire and the Humber, Channel Islands, Isle of Man

Value of contract

£710,767,138

Procurement reference

CF-0218500D0O000000rwimUAA1

Published date

21 June 2021

Closing date

26 July 2021

Closing time

1pm

Contract start date

1 February 2022

Contract end date

31 May 2024

Contract type

Supply contract

Procedure type

Open (non-OJEU)

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

 

Description

 

Tender Close: 26th July 2021, 13:00.
Invitation to offer for NHS National Generic Pharmaceuticals Wave 13
Offer reference number: CM/PHG/17/5532
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority’s sole discretion) for a period or periods up to a total of 48 months.

Potential periods of call-offs under the framework agreement:

Transition (Everolimus)
CESW: 1 March 2022 – 30 September 2023 (19 months)
LSNE: 1 March 2022 – 31 January 2023 (11 months)
NWLN: 1 March 2022 – 31 January 2023 (11 months)

Oral Products plus non-parenterals
All Regions: 1 March 2022 – 31 May 2024 (27 months)

Hospital Only Products
CESW: 1 February 2022 – 30 September 2023 (20 months)
LSNE: 1 February 2022 – 31 May 2024 (28 months)
NWLN: 1 February 2022 – 31 January 2023 (12 months)

 

More information

 

Links

 

How to apply

 

Follow the instructions given in the description or the more information section.

 

About the buyer

 

Contact name

Gemma Tomlinson / Lynne Tierney

Address

2nd Floor Rutland House
Runcorn
WA7 2ES
UK

Email

gemma.tomlinson1@nhs.net